ArticleCureus2022

Efficacy and Safety of Hydroxyurea as Adjuvant Therapy in Pediatric Patients of Transfusion-Dependent Beta-Thalassemia Major at Zhob, Balochistan.

Sumera Akram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.